ADMA Biologics, Inc.
US ˙ NasdaqGM ˙ US0008991046

SecurityADMA / ADMA Biologics, Inc.
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership30,651 shares
Latest Disclosed Value $ 276,164
Advisor Group Holdings, Inc. reports 162.72% increase in ownership of ADMA / ADMA Biologics, Inc.

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 30,651 shares of ADMA Biologics, Inc. (US:ADMA) valued at $276,166 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 11,667 shares of ADMA Biologics, Inc.. This represents a change in shares of 162.72% during the quarter. The current value of the position is $244,288 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ADMA BIOLOGICS COM 000899104 30,651 18,984 162.72 276 30.19 0.0002
2026-02-17 2025-12-31 13F ADMA BIOLOGICS COM 000899104 11,667 -42,561 -78.49 213 -76.91 0.0003
2025-11-14 2025-09-30 13F ADMA BIOLOGICS COM 000899104 54,228 -11,944 -18.05 918 -23.75 0.0013
2025-09-04 2025-06-30 13F/A-1 DMA BIOLOGICS COM 000899104 66,172 -1,575 -2.32 1,205 -10.35 0.0021
2025-08-13 2025-06-30 13F DMA BIOLOGICS COM 000899104 9,186 -58,561 162 0.0002
2025-05-12 2025-03-31 13F ADMA BIOLOGICS COM 000899104 67,747 56,910 525.15 1,344 625.95 0.0030
2025-06-06 2024-12-31 13F/A-1 ADMA BIOLOGICS COM 000899104 10,837 -2,861 -20.89 186 -32.23 0.0004
2025-02-07 2024-12-31 13F ADMA BIOLOGICS COM 000899104 17,582 3,884 335 0.0009
2024-11-13 2024-09-30 13F ADMA BIOLOGICS COM 000899104 13,698 -62,364 -81.99 274 -67.88 0.0006
2024-08-13 2024-06-30 13F ADMA BIOLOGICS COM 000899104 76,062 33,978 80.74 850 206.86 0.0020
2024-05-10 2024-03-31 13F ADMA BIOLOGICS COM 000899104 42,084 520 1.25 278 48.13 0.0006
2024-02-12 2023-12-31 13F ADMA BIOLOGICS COM 000899104 41,564 1,117 2.76 188 29.86 0.0003
2023-11-13 2023-09-30 13F ADMA BIOLOGICS COM 000899104 40,447 5,634 16.18 145 12.50 0.0002
2023-08-21 2023-06-30 13F/A-1 ADMA BIOLOGICS COM 000899104 34,813 -1,854 -5.06 128 5.79 0.0002
2023-08-10 2023-06-30 13F ADMA BIOLOGICS COM 000899104 34,813 -1,854 128 0.0000
2023-05-12 2023-03-31 13F ADMA BIOLOGICS COM 000899104 36,667 741 2.06 121 -12.32 0.0002
2023-02-10 2022-12-31 13F ADMA BIOLOGICS COM 000899104 35,926 0 0.00 139 58.62 0.0003
2022-11-14 2022-09-30 13F ADMA BIOLOGICS COM 000899104 35,926 2,000 5.90 87 29.85 0.0002
2022-08-10 2022-06-30 13F ADMA BIOLOGICS COM 000899104 33,926 28,650 543.03 67 644.44 0.0001
2022-05-04 2022-03-31 13F ADMA BIOLOGICS COM 000899104 5,276 1,000 23.39 9 50.00 0.0000
2022-02-03 2021-12-31 13F ADMA BIOLOGICS COM 000899104 4,276 -8,098 -65.44 6 -57.14 0.0000
2021-11-05 2021-09-30 13F ADMA BIOLOGICS COM 000899104 12,374 -1,500 -10.81 14 -39.13 0.0000
2021-08-02 2021-06-30 13F ADMA BIOLOGICS COM 000899104 13,874 -10,366 -42.76 23 -45.24 0.0000
2021-05-13 2021-03-31 13F ADMA BIOLOGICS COM 000899104 24,240 -19,954 -45.15 42 -51.16 0.0001
2021-02-10 2020-12-31 13F ADMA BIOLOGICS COM 000899104 44,194 9,759 28.34 86 4.88 0.0002
2020-11-12 2020-09-30 13F ADMA BIOLOGICS COM 000899104 34,435 29,435 588.70 82 446.67 0.0002
2020-08-14 2020-06-30 13F ADMA BIOLOGICS COM 000899104 5,000 5,000 15 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.